China Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

China Pharmaceuticals and Healthcare Report

China Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
China Pharmaceuticals and Healthcare Report
Published Jul 23, 2016
162 pages — Published Jul 23, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In June ----, Novartis opened a new research facility in Shanghai which costs USD-bn. This new center will be company s third major research center after Basel in Switzerland and Cambridge in Massachusetts. ...That same month, the Chinese government unveiled new guidelines to extend the family doctor system nationwide. With a pilot programme expected to be launched in ----, the government aims to have a family doctor contracted to every household by ----. In July ----, the National Development and Reform Commission announced reforms to medical pricing in the country. ...In July ----, the National Development and Reform Commission announced reforms to medical pricing in the country. According to guidelines released, hospitals will be allowed to charge more for registration fees, operations, nursing care and traditional Chinese medicine.

...BMI View: China will become a leading medical research hub within the Asia Pacific region. This will be largely led by multinational pharmaceutical firms as they seek to tap the large talent pool within the country and develop treatments in China, for China . ...BMI View: China will become a leading medical research hub within the Asia Pacific region. This will be largely led by multinational pharmaceutical firms as they seek to tap the large talent pool within the country and develop treatments in China, for China . The local industry, while still largely focused on generic drugs, has started to shift towards developing innovative treatments. ...The local industry, while still largely focused on generic drugs, has started to shift towards developing innovative treatments. Together with the partnerships formed with multinational drugmakers, investments into research by Chinese firms will grow and contribute to the country s flourishing drug discovery sector.

...All information contained in this publication is copyrighted in the name of Business Monitor International Ltd, and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher. ...

...

  
Source:
Document ID
1748-1821
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "China Pharmaceuticals and Healthcare Report" Jul 23, 2016. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/China-Pharmaceuticals-and-Healthcare-Report-2026-112>
  
APA:
Business Monitor International - Industry Reports. (2016). China Pharmaceuticals and Healthcare Report Jul 23, 2016. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/China-Pharmaceuticals-and-Healthcare-Report-2026-112>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.